Generic drug in Indonesia: why physicians and pharmacists matters Online publication date: Mon, 06-Aug-2018
by Amelia Amelia; Ronald Ronald
International Journal of Monetary Economics and Finance (IJMEF), Vol. 11, No. 3, 2018
Abstract: Since 2014, Indonesia began imposing the National Health Insurance program. One of the goals of implementing the program is to increase the use of generic drugs. This action was done to respond the low use of generic drugs, which is around 11%, in 2011 (World Bank, 2008). Therefore, this study tried to examine the factors that influence the purchase intention of generic drugs based on the information from physicians and pharmacists. Also the overall information risk with experience was used as moderating variable. The research sample for this includes 400 respondents. The questionnaires were distributed from September 2014 until December 2015. The questionnaire distribution takes a relatively long time due to the very small number of generic drug users were available. The result shows that physician information have the biggest effect on the purchase intention of generic drugs, and that experience has a significant effect as moderating variable.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Monetary Economics and Finance (IJMEF):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com
Our Blog 
Follow us on Twitter 
Visit us on Facebook